• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Gold Drops Over 1%; Existing Home Sales Surge In February

    3/21/23 12:05:57 PM ET
    $AG
    $ALT
    $CHEK
    $CISO
    Precious Metals
    Basic Materials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AG alert in real time by email

    U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Tuesday.

    The Dow traded up 0.65% to 32,455.57 while the NASDAQ rose 0.57% to 11,741.91. The S&P 500, also rose, gaining, 0.70% to 3,979.20.

    Check This Out: Meta Platforms To Rally Over 26%? Here Are 10 Other Analyst Forecasts For Tuesday

     

    Leading and Lagging Sectors

    • Energy shares rose by 2.5% on Tuesday. Meanwhile, top gainers in the sector included Select Energy Services, Inc. (NYSE:WTTR), up 13%, and Diamond Offshore Drilling, Inc. (NYSE:DO), up 15%.
    • In trading on Tuesday, utilities shares fell 1.4%.

     

    Top Headline

    Existing home sales in the US surged 14.5% to an annual rate of 4.58 million in February, compared to market estimates of a 5% growth.

     

    Equities Trading UP

    • Quince Therapeutics, Inc. (NASDAQ:QNCX) shares shot up 68% to $1.41 after Echo Lake Capital offered to acquire the company for $1.60 per share in cash.
    • Shares of Cerberus Cyber Sentinel Corporation (NASDAQ:CISO) got a boost, shooting 74% to $0.4001. Cerberus Cyber Sentinel said it sees Q4 revenue of $14.7 million and sees FY22 revenue of $46.5 million. CISO proposed using the offering proceeds and its existing cash resources to repay the $5,000,000 4% promissory note issued and sold to Bell Bank in June 2022.
    • U.S. Xpress Enterprises, Inc. (NYSE:USX) shares were also up, gaining 299% to $5.98 after Knight-Swift Transportation agreed to acquire the company for $6.15 per share.

     

    Equities Trading DOWN

    • Altimmune, Inc. (NASDAQ:ALT) shares tumbled 52% to $5.21 after the company announced results from the week 24 interim analysis of pemvidutide MOMENTUM Phase 2 obesity trial and 12-week Phase 1b type 2 diabetes safety trial.
    • Shares of Check-Cap Ltd. (NASDAQ:CHEK) were down 40% to $1.83 after the company said the current efficacy results from its calibration studies do not meet the goal to proceed to the powered portion of the U.S. pivotal study.
    • First Majestic Silver Corp. (NYSE:AG) was down, falling 25% to $5.61 after the company temporarily suspended mining activities and reduced its workforce at Jerritt Canyon, which represented 21% of the company's 2022 revenue.

    Also Check This Out: Top 3 Consumer Stocks That You May Want To Dump In March

     

    Commodities

    In commodity news, oil traded up 1.6% to $68.75 while gold traded down 1.4% at $1,955.60.

    Silver traded down 0.7% to $22.485 on Tuesday while copper rose 1% to $3.9920.

     

    Euro zone

    European shares were higher today. The eurozone’s STOXX 600 gained 1.39%, London’s FTSE 100 rose 1.71% while Spain’s IBEX 35 Index rose 2.61%. The German DAX gained 1.78%, French CAC 40 climbed 1.5% and Italy’s FTSE MIB Index rose 2.58%.

    Construction output in the Eurozone rose 0.9% from a year ago in January. The ZEW Indicator of Economic Sentiment for the Eurozone fell by 19.7 points to 10 in March versus a one-year high level of 29.7 in the previous month, while ZEW Indicator of Economic Sentiment for Germany declined by 15.1 points to 13 in March. Passenger car registrations in the European Union rose 11.5% year-over-year to 802,763 units in February.

     

    Asia Pacific Markets

    Asian markets closed higher on Tuesday, with Hong Kong’s Hang Seng Index gaining 1.36% and China’s Shanghai Composite Index gaining 0.64%. India’s S&P BSE Sensex rose 0.77%.

    Hong Kong’s current account surplus shrank to HKD 63.8 billion in the fourth quarter from HKD 91.9 billion in the year-ago period.

     

    Economics

    Existing home sales in the US surged 14.5% to an annual rate of 4.58 million in February, compared to market estimates of a 5% growth.

    Now Read This: Insiders Selling Roblox And 2 Other Stocks

     

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 105,979,970 cases with around 1,151,770 deaths. India confirmed a total of at least 44,696,980 cases and 530,800 deaths, while France reported over 39,704,740 COVID-19 cases with 165,370 deaths. In total, there were at least 682,658,200 cases of COVID-19 worldwide with more than 6,820,840 deaths.

    Get the next $AG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AG
    $ALT
    $CHEK
    $CISO

    CompanyDatePrice TargetRatingAnalyst
    Select Water Solutions Inc.
    $WTTR
    2/19/2026$18.00Market Perform → Outperform
    Northland Capital
    Quince Therapeutics Inc.
    $QNCX
    1/30/2026Mkt Outperform → Mkt Perform
    Citizens JMP
    Altimmune Inc.
    $ALT
    1/28/2026$20.00Overweight
    Barclays
    Select Water Solutions Inc.
    $WTTR
    11/13/2025$12.00Outperform → Market Perform
    Northland Capital
    First Majestic Silver Corp.
    $AG
    10/8/2025Hold → Buy
    TD Securities
    Quince Therapeutics Inc.
    $QNCX
    8/5/2025$9.00Mkt Outperform
    Citizens JMP
    Select Water Solutions Inc.
    $WTTR
    7/15/2025$15.00Overweight
    Piper Sandler
    Altimmune Inc.
    $ALT
    7/10/2025$1.00Sell
    Goldman
    More analyst ratings

    $AG
    $ALT
    $CHEK
    $CISO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Altimmune to Participate in Upcoming Investor Conferences

    GAITHERSBURG, Md., March 02, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that management will participate and be available for one-on-one meetings at the following investor conferences: Leerink Global Healthcare Conference Monday, March 9, 2026 – One-on-one meetingsWednesday, March 11, 2026 – Fireside chat at 9:20 a.m. ET Citizens Life Sciences Conference Tuesday, March 10, 2026 – One-on-one meetings Fireside chat at 2:15 p.m. ET Jefferies Biotech on the Beach SummitWednesday, March 11, 2026 – One-on-one meetings only Barclays 28th Annual Global Healthcar

    3/2/26 7:30:00 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Altimmune to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026

    GAITHERSBURG, Md., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that it will report its fourth quarter 2025 financial results on Thursday, March 5, 2026. Altimmune management will host a conference call at 8:30 a.m. ET on March 5 to discuss the financial results and provide a business update. The conference call will be webcast live on Altimmune's Investor Relations website at https://ir.altimmune.com/investors. Participants who would like to join the call may register here to receive dial-in numbers and a unique PIN. A replay will be available on t

    2/26/26 7:30:00 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CISO Global Appoints Dhaval Damania as EVP of Cybersecurity & IT

    Experienced AI and enterprise IT operations leader joins Company to accelerate scalable growth, strengthen security architecture, and advance next-generation cyber software innovation Scottsdale, Ariz., Feb. 23, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ:CISO) ("CISO Global" or the "Company"), a provider of AI-powered cybersecurity software and compliance services, today announced the appointment of Dhaval Damania as Executive Vice President of Cybersecurity & IT. This appointment reinforces its continued commitment to operational excellence, innovation, and scalable growth across its next-generation cybersecurity software portfolio. In this role, Damania will lead CISO Global's

    2/23/26 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    $AG
    $ALT
    $CHEK
    $CISO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Select Water Solutions upgraded by Northland Capital with a new price target

    Northland Capital upgraded Select Water Solutions from Market Perform to Outperform and set a new price target of $18.00

    2/19/26 7:40:27 AM ET
    $WTTR
    Oilfield Services/Equipment
    Energy

    Quince Therapeutics downgraded by Citizens JMP

    Citizens JMP downgraded Quince Therapeutics from Mkt Outperform to Mkt Perform

    1/30/26 6:43:10 AM ET
    $QNCX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Barclays initiated coverage on Altimmune with a new price target

    Barclays initiated coverage of Altimmune with a rating of Overweight and set a new price target of $20.00

    1/28/26 7:15:18 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AG
    $ALT
    $CHEK
    $CISO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Scientific Officer Roberts M Scot

    4 - Altimmune, Inc. (0001326190) (Issuer)

    2/27/26 4:10:07 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chief Financial Officer Weaver Gregory L

    4 - Altimmune, Inc. (0001326190) (Issuer)

    2/27/26 4:05:36 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: EVP, Business Strategy Ortowski Cody was granted 32,552 shares and covered exercise/tax liability with 14,694 shares, increasing direct ownership by 5% to 402,372 units (SEC Form 4)

    4/A - Select Water Solutions, Inc. (0001693256) (Issuer)

    2/26/26 4:13:23 PM ET
    $WTTR
    Oilfield Services/Equipment
    Energy

    $AG
    $ALT
    $CHEK
    $CISO
    SEC Filings

    View All

    Select Water Solutions Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Select Water Solutions, Inc. (0001693256) (Filer)

    2/25/26 8:56:13 AM ET
    $WTTR
    Oilfield Services/Equipment
    Energy

    Select Water Solutions Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Select Water Solutions, Inc. (0001693256) (Filer)

    2/23/26 8:37:39 AM ET
    $WTTR
    Oilfield Services/Equipment
    Energy

    SEC Form 424B5 filed by Select Water Solutions Inc.

    424B5 - Select Water Solutions, Inc. (0001693256) (Filer)

    2/23/26 8:30:54 AM ET
    $WTTR
    Oilfield Services/Equipment
    Energy

    $AG
    $ALT
    $CHEK
    $CISO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Pisano Wayne bought $20,410 worth of shares (5,000 units at $4.08), increasing direct ownership by 59% to 13,498 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    1/9/26 4:10:05 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Sohn Catherine A. bought $2,118 worth of shares (500 units at $4.24), increasing direct ownership by 50% to 1,500 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    1/5/26 4:05:39 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Jorkasky Diane bought $2,003 worth of shares (527 units at $3.80) (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    12/29/25 4:10:05 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AG
    $ALT
    $CHEK
    $CISO
    Leadership Updates

    Live Leadership Updates

    View All

    CISO Global Appoints Dhaval Damania as EVP of Cybersecurity & IT

    Experienced AI and enterprise IT operations leader joins Company to accelerate scalable growth, strengthen security architecture, and advance next-generation cyber software innovation Scottsdale, Ariz., Feb. 23, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ:CISO) ("CISO Global" or the "Company"), a provider of AI-powered cybersecurity software and compliance services, today announced the appointment of Dhaval Damania as Executive Vice President of Cybersecurity & IT. This appointment reinforces its continued commitment to operational excellence, innovation, and scalable growth across its next-generation cybersecurity software portfolio. In this role, Damania will lead CISO Global's

    2/23/26 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    CISO Global Lands 30 Year Sales Veteran Michael Czerneda to Ignite the Next Wave of Software Growth

    New Vice President of Sales to accelerate software-driven growth across cyber services platform and insurance distribution channels  Scottsdale, Ariz., Feb. 18, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ:CISO) ("CISO Global" or the "Company"), a provider of AI-powered cybersecurity software and compliance services, today announced the appointment of Michael Czerneda as Vice President of Sales. In this role, Czerneda will lead enterprise-wide sales initiatives as the Company accelerates its transition toward scalable, software-driven growth built on its established cyber services platform.  Czerneda brings more than 30 years of sales leadership experience spanning UCaaS, CCaaS, da

    2/18/26 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    CISO Global Partners with TeleDental to Launch CyberSimple® Powered by CHECKLIGHT® to Protect Dental Clinics From Cyber Threats

    Scottsdale, AZ, Jan. 15, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ:CISO), a leading provider of AI-powered cybersecurity software and compliance services, today announced a strategic partnership with TeleDental.com and DentalChat.com to offer Cyber Assurance Group's CyberSimple® powered by CHECKLIGHT®, delivering cybersecurity and financial protection purpose-built for dental practices. Through this collaboration, CyberSimple® powered by CHECKLIGHT® will be made available via TeleDental.com and DentalChat.com, initially extending protection to more than 358 dental clinics nationwide, with significant expansion potential across the broader U.S. dental market. This effort underline

    1/15/26 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    $AG
    $ALT
    $CHEK
    $CISO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Quince Therapeutics Inc.

    SC 13G/A - Quince Therapeutics, Inc. (0001662774) (Subject)

    11/14/24 4:00:05 PM ET
    $QNCX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Altimmune Inc.

    SC 13G/A - Altimmune, Inc. (0001326190) (Subject)

    11/14/24 11:58:56 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13D filed by Quince Therapeutics Inc.

    SC 13D - Quince Therapeutics, Inc. (0001662774) (Subject)

    11/13/24 9:17:26 PM ET
    $QNCX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AG
    $ALT
    $CHEK
    $CISO
    Financials

    Live finance-specific insights

    View All

    Altimmune to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026

    GAITHERSBURG, Md., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that it will report its fourth quarter 2025 financial results on Thursday, March 5, 2026. Altimmune management will host a conference call at 8:30 a.m. ET on March 5 to discuss the financial results and provide a business update. The conference call will be webcast live on Altimmune's Investor Relations website at https://ir.altimmune.com/investors. Participants who would like to join the call may register here to receive dial-in numbers and a unique PIN. A replay will be available on t

    2/26/26 7:30:00 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    First Majestic Reports Q4 2025 and Full Year 2025 Financial Results; Announces Quarterly Dividend Payment

    Vancouver, British Columbia--(Newsfile Corp. - February 19, 2026) - First Majestic Silver Corp. (NYSE:AG) (TSX:AG) (FSE: FMV) (the "Company" or "First Majestic") is pleased to announce the Company's audited consolidated financial results for the fourth quarter and year end ended December 31, 2025. The full version of the annual financial statements and the accompanying management's discussion and analysis can be viewed on the Company's website at www.firstmajestic.com or on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov/edgar. All amounts are in U.S. dollars unless stated otherwise.FOURTH QUARTER HIGHLIGHTSRecord Quarterly Silver Production (+77% Y/Y): The Company achieved record qua

    2/19/26 7:00:00 AM ET
    $AG
    Precious Metals
    Basic Materials

    Select Water Solutions Announces Fourth Quarter and Full Year 2025 Financial and Operational Results and Strategic Updates

    Generated full year and fourth quarter 2025 consolidated revenue of $1.4 billion and $347 million, respectivelyGenerated full year net income of $21 million and Adjusted EBITDA of $260 millionWater Infrastructure generated full year 2025 revenues of $313 million, up 8% year-over-yearChemical Technologies generated full year 2025 revenues of $308 million, up 19% year-over-yearAnnounces multiple new long-term contracted Water Infrastructure projects supported by 15 million barrels of minimum volume commitments ("MVC") and approximately 180,000 acres of new leasehold and ROFR acreage dedicationsGAINESVILLE, Texas, Feb. 17, 2026 /PRNewswire/ -- Select Water Solutions, Inc. (NYSE: WTTR) ("Select,

    2/17/26 4:15:00 PM ET
    $WTTR
    Oilfield Services/Equipment
    Energy